TITLE

Stem cell therapy: hope or hype?

AUTHOR(S)
Braude, Peter; Minger, Stephen L.; Warwick, Ruth M.
PUB. DATE
May 2005
SOURCE
BMJ: British Medical Journal (International Edition);5/21/2005, Vol. 330 Issue 7501, p1159
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
Presents an editorial on how the safety and quality of stem cell therapy must be assured before the treatment can benefit patients. Potential of stem cell therapy to fight degenerative disorders, such as diabetes and heart disease; How the number of human embryonic stem cell lines increased considerably from 2002 to 2004, but no stem cells have been grown in conditions that would be expected for a pharmaceutical product destined for consumer use; How the drive to be the first to provide cell lines for therapy could compromise safety.
ACCESSION #
17127178

 

Related Articles

  • Stem Cell Therapeutics: Exploring Newer Alternatives to Human Embryonic Stem Cells. Garg, Abhishek D. // Internet Journal of Health;2008, Vol. 8 Issue 1, p16 

    Stem cells therapeutics has come a long way since stem cells and their potential was discovered for the first time. Intense research into cellular biology of stem cells has revealed that they possess immense potential for curing many human diseases. Research done in last couple of decades...

  • Medicine: Politic stem cells. Weissman, Irving L. // Nature;1/12/2006, Vol. 439 Issue 7073, p145 

    The article discusses the methods in producing pluripotent stem-cell lines for understanding and treating diseases. One method involves cell removal from its stages of developments. The embryonic stem cells produced in these method would have the same gene as the embryo. The production of such...

  • Modern minotaur. Cohen, Philip // New Scientist;11/21/98, Vol. 160 Issue 2161, p14 

    Focuses on research at Advanced Cell Technology (ACT) of Worcester, Massachusetts that has successfully harvested embryonic stem cells from cross-species embryos. Why ACT chief executive officer Michael West decided to go public with the research; Brief description of research done by Jose...

  • Stem cells: Scorecards for pluripotent cell lines. Muers, Mary // Nature Reviews Genetics;Mar2011, Vol. 12 Issue 3, p153 

    The article discusses a study on the differences among human induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) and between each cell lines which references the study "Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent...

  • New Human Embryonic Stem-Cell Lines to Be Made Available to Researchers.  // Ascribe Newswire: Medicine;3/4/2004, p20 

    Howard Hughes Medical Institute researchers at Harvard University announced today that they have derived 17 new human embryonic stem-cell lines. The new cell lines will be made available to researchers, although at this time United States policies prohibit the use of federal funds to investigate...

  • Human embryonic stem cells: preclinical perspectives. Deb, Kaushik Dilip; Sarda, Kanchan // Journal of Translational Medicine;2008, Vol. 6, Special section p1 

    Human embryonic stem cells (hESCs) have been extensively discussed in public and scientific communities for their potential in treating diseases and injuries. However, not much has been achieved in turning them into safe therapeutic agents. The hurdles in transforming hESCs to therapies start...

  • Derivation of Embryonic Stem-Cell Lines from Human Blastocysts. Cowan, Chad A.; Klimanskaya, Irina; McMahon, Jill; Atienza, Jocelyn; Witmyer, Jeannine; Zucker, Jacob P.; Wang, Shunping; Morton, Cynthia C.; McMahon, Andrew P.; Powers, Doug; Melton, Douglas A. // New England Journal of Medicine;3/25/2004, Vol. 350 Issue 13, p1353 

    Reports on the development of 17 additional human embryonic stem cell lines. Frozen cleavage- and blastocyst-stage human embryos produced by in vitro fertilization for clinical purposes; How many were cultured to the blastcyst stage and allowed to re-expand; How the rest of the procedure went to...

  • CELL DIVISION.  // Current Events;3/23/2009, Vol. 108 Issue 20, p2 

    The article reports that a ban on federally funded research on new embryonic stem cell lines was lifted by U.S. President Barack Obama on March 9, 2009. It notes that this kind of research might pave the way to finding cures for hundreds of human ailments, including diabetes and cancer....

  • Preimplantation genetic diagnosis as a novel source of embryos for stem cell research. Pickering, Sue; Braude, Peter R.; Patel, Minal; Burns, Chris J.; Trussler, Jane; Bolton, Virginia; Minger, Stephen // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Oct2003, Vol. 7 Issue 3, p353 

    The generation of human embryonic stem (hES) cells has captured the public and professional imagination, largely due their potential as a means of overcoming many debilitating and degenerative diseases by cell replacement therapy. Despite this potential, few well-characterized hES cell lines...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics